MedPath

A STUDY ON SIDDHA HERBAL MEDICINE AAVARAI KIRUTHAMFOR THE DIABETES NEUROLOGICAL COMPLICATION(MADHUMEGA AVATHAIGAL)

Phase 3
Completed
Conditions
Health Condition 1: E084- Diabetes mellitus due to underlying condition with neurological complications
Registration Number
CTRI/2019/08/020765
Lead Sponsor
AYOTHIDOSS PANDITHAR HOSPITA
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Completed
Sex
Not specified
Target Recruitment
60
Inclusion Criteria

BLOOD SUGAR FASTING >126 mg/dl and >200,post prandial blood sugar >200 and <350 mg/dl,GLYCATED HAEMOGLOBIN > 7% AND < 11%,DIABETES PERIPHERAL NEUROPATHY MADHUMEGA AVATHAIGAL,PATIENT WHO IS ALREADY UNDER SIDDHA MEDICATION FOR MADHUMEGAM,DIABETES WITH HYPERTENSION.

Exclusion Criteria

AGE BETWEEN 30 YEARS TO 65 YEARS BOTH GENDER,GLYCATED HAEMOGLOBIN < 7% AND > 11%,

INSULIN DEPENDENT DIABETES MELLITUS,SECONTARY DIABETES MELLITUS,PREGNANT WOMEN AND PLANNING TO BE PREGNANT WITHIN 3 MONTHS,GESTATIONAL DIABETES,EXISTING RENAL FAILURE INDICATED BY ELEVATED SERUM CREATININE LEVELS,CNS DISORDER CORONARY ARTERY DISEASE,THYROID DYSFUNCTION ,MALIGNANT AND ACCELERATED HYPERTENSIVE,SUBJECT THOSE WHO ARE NOT WILLING TO GIVING INFORMED CONCENT.

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
PRIMARY OUTCOME IS ASSESSED BY COMPARING THE BLOOD SUGAR HbA1C LEVEL AND DIABETIC PERIPHERAL NEUROPATHY SCALE BOTH GROUPS BEFORE AND AFTER TREATMENT ASSESMENTTimepoint: 90 DAYS
Secondary Outcome Measures
NameTimeMethod
SECONDARY OUTCOME WILL BE ASSESSED BY COMPARING THE FOLLOWING THREE PARAMETERS PRE AND POST TREATMENT CHANGES IN SIDDHA CLINICAL PARAMETERS.EVALUATING CLINICAL LAB PARAMETERS.Timepoint: 90 DAYS
© Copyright 2025. All Rights Reserved by MedPath